Eric C. Burton, M.D.
Dr. Burton's primary clinical interest is adults with primary brain tumors. His research is based in the clinic and is focused on the conduct of phase I and II clinical trials that help to develop new therapies for patients with these tumors. Dr. Burton also has an interest in population-based brain tumor research which focuses on defining optimal treatment approaches.
1) primary brain tumors
2) clinical trial research
3) population-based brain tumor studies
Dr. Burton is a neuro-oncologist in the Neuro-Oncology Branch of the NCI's Center for Cancer Research. His research is based in the neuro-oncology clinic. His focus is on conducting phase I and II clinical trials to develop new therapies for patients with brain tumors.
Selected Key Publications
Phase I study of erlotinib HCI alone and combined with temozolomide in patients with stable or recurrent malignant glioma.Neuro-Oncology. 8(1): 67-78, 2006. [ Journal Article ]
A Surveillance, Epidemiology and End Results-Medicare data analysis of elderly patients with glioblastoma multiforme: Treatment patterns, outcomes and cost.Molecular and Clinical Oncology. 3(5): 971-978, 2015. [ Journal Article ]
Survival in elderly patients with glioblastoma in the USA: A comparison of bevacizumab-based and non-bevacizumab-based regimens.Neuro-Oncology Practice. [ Journal Article ]
Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients Over 70 Years Old with Newly Diagnosed Glioblastoma.Oncology. 95(1): 95(1), 2018. [ Journal Article ]
Survival Impact of Prolonged Radiation Therapy for Patients with Glioblastoma Treated with Combined-Modality Therapy.Neuro-Oncology Practice. [ Journal Article ]
Dr. Burton earned his medical degree from the University of Michigan (Ann Arbor, MI). Following graduation, he completed a residency in neurology at the University of Chicago (Chicago, IL) followed by a fellowship in neuro-oncology at the University of California San Francisco (UCSF). Dr. Burton joined the NCI from the University of Louisville Brown Cancer Center where he served as Director of Neuro-Oncology.
Dr. Burton is board certified in neurology and neuro-oncology. He received his M.D. degree with distinction, and while at UCSF was honored to receive the Robert Magnin Newman fellowship award. In Louisville he was named by his peers as “Top Doctor”.